Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

New positive data for Janssen's esketamine depression treatment, MSD buys Peloton Therapeutics for $2.1 billion, and Gilead CEO grilled on why its...
GSK’s shingles vaccine has secured approval in China, the company said, after the National Medical Products Administration (NMPA) authorised the...
Janssen has unveiled a new cost-effectiveness analysis for its recently FDA-approved nasal spray Spravato (esketamine) in the treatment of...
Akcea Therapeutics’ Tegsedi (inotersen) has received recommendation from NICE, the company has revealed, meaning the therapy will now be made...
Takeda has announced that Japan’s drug regulator, the Ministry of Health, Labour and Welfare (MHLW), has approved Entyvio (vedolizumab) in the...
AbbVie has terminated a Phase 3 study of the efficacy of Depatux-M in the treatment of newly diagnosed glioblastoma (GBM) in patients whose tumours...
Boehringer has announced that Pradaxa has failed to meet its primary endpoint in its Phase 3 study, proving unable to show superiority over...
Takeda has unveiled exploratory data on Entyvio, demonstrating its superiority over AbbVie’s Humira in achieving remission in moderately to...
Sandoz has revealed that its generic statin rosuvastatin, known in its branded incarnation as Crestor, has been given approval in China from the...
The expanded indication relates specifically to adult patients who are not eligible for stem cell transplant and only where thalidomide cannot be...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches